Physician profile
Stephen T Olson
NPI 1124247887
$1,084.34
in general payments reported to CMS, 2019-2025
8 companies · $98.21 in 2025
The $98.21 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $270 · 2021: $519 · 2022: $87.61 · 2023: $42.48 · 2024: $66.78 · 2025: $98.21.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $207.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $207.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $550.26 | 2020-2025 | Pangea, Gamma, Triathlon |
| Zimmer Biomet Holdings, INC. | $281.23 | 2021 | |
| Depuy Synthes Sales INC. | $117.69 | 2021 | |
| Bioventus LLC | $44.04 | 2023-2025 | Durolane, Durolane |
| Vertex Pharmaceuticals Incorporated | $27.36 | 2025 | |
| Alphatec Spine, INC | $24.04 | 2023 | Invictus Mis |
| Ferring Pharmaceuticals INC. | $21.00 | 2022 | |
| Smith+Nephew, INC. | $18.72 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Olson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.